Foshaug T - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Virologic Response and Reinfection Following HCV Treatment among Hospitalized People Who Inject Drugs: Follow-Up Data from the OPPORTUNI-C Trial.

Malme KB, Stene-Johansen K, Klundby I, Backe Ø, Foshaug T, Greve MH, Pihl CM, Finbråten AK, Dalgard O, Midgard H. Malme KB, et al. Among authors: foshaug t. Viruses. 2024 May 27;16(6):858. doi: 10.3390/v16060858. Viruses. 2024. PMID: 38932151 Free PMC article.

Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs.

Opheim E, Dalgard O, Ulstein K, Sørli H, Backe Ø, Foshaug T, Couëssurel Wüsthoff LE, Midgard H. Opheim E, et al. Among authors: foshaug t. Int J Drug Policy. 2024 Jan;123:104279. doi: 10.1016/j.drugpo.2023.104279. Epub 2023 Dec 6. Int J Drug Policy. 2024. PMID: 38061225

Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway.

Midgard H, Ulstein K, Backe Ø, Foshaug T, Sørli H, Vennesland K, Nilssen D, Dahl EH, Finbråten AK, Wüsthoff L, Dalgard O. Midgard H, et al. Among authors: foshaug t. Int J Drug Policy. 2021 Oct;96:103165. doi: 10.1016/j.drugpo.2021.103165. Epub 2021 Feb 26. Int J Drug Policy. 2021. PMID: 33642182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters